ID AT2B2_HUMAN Reviewed; 1243 AA. AC Q01814; O00766; Q12994; Q16818; DT 01-JUL-1993, integrated into UniProtKB/Swiss-Prot. DT 01-JUN-2001, sequence version 2. DT 07-OCT-2020, entry version 215. DE RecName: Full=Plasma membrane calcium-transporting ATPase 2; DE Short=PMCA2; DE EC=7.2.2.10; DE AltName: Full=Plasma membrane calcium ATPase isoform 2; DE AltName: Full=Plasma membrane calcium pump isoform 2; GN Name=ATP2B2; Synonyms=PMCA2; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ZB). RC TISSUE=Brain; RX PubMed=1427863; DOI=10.1016/s0888-7543(05)80246-0; RA Brandt P., Ibrahim E., Bruns G.A.P., Neve R.L.; RT "Determination of the nucleotide sequence and chromosomal localization of RT the ATP2B2 gene encoding human Ca(2+)-pumping ATPase isoform PMCA2."; RL Genomics 14:484-487(1992). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ZB), AND ALTERNATIVE SPLICING. RX PubMed=8428366; RA Latif F., Duh F.-M., Gnarra J., Tory K., Kuzmin I., Yao M., Stackhouse T., RA Modi W., Geil L., Schmidt L., Li H., Orcutt M.L., Maher E., Richards F., RA Phipps M., Ferguson-Smith M., le Paslier D., Linehan W.M., Zbar B., RA Lerman M.I.; RT "von Hippel-Lindau syndrome: cloning and identification of the plasma RT membrane Ca(++)-transporting ATPase isoform 2 gene that resides in the von RT Hippel-Lindau gene region."; RL Cancer Res. 53:861-867(1993). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM WB), AND ALTERNATIVE SPLICING. RC TISSUE=Brain, and Skeletal muscle; RX PubMed=1313367; DOI=10.1111/j.1432-1033.1992.tb16784.x; RA Heim R., Hug M., Iwata T., Strehler E.E., Carafoli E.; RT "Microdiversity of human-plasma-membrane calcium-pump isoform 2 generated RT by alternative RNA splicing in the N-terminal coding region."; RL Eur. J. Biochem. 205:333-340(1992). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16641997; DOI=10.1038/nature04728; RA Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J., RA Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P., RA Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A., RA Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L., RA Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G., RA Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W., RA Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., RA Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P., RA Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H., RA Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., RA Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., RA Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., RA Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., RA Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B., RA Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H., RA Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J., RA Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X., RA Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R., RA Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.; RT "The DNA sequence, annotation and analysis of human chromosome 3."; RL Nature 440:1194-1198(2006). RN [5] RP PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS WA/YA/ZA). RC TISSUE=Brain cortex; RX PubMed=8245032; RA Stauffer T.P., Hilfiker H., Carafoli E., Strehler E.E.; RT "Quantitative analysis of alternative splicing options of human plasma RT membrane calcium pump genes."; RL J. Biol. Chem. 268:25993-26003(1993). RN [6] RP ERRATUM OF PUBMED:8245032. RX PubMed=7989379; RA Stauffer T.P., Hilfiker H., Carafoli E., Strehler E.E.; RL J. Biol. Chem. 269:32022-32022(1994). RN [7] RP INTERACTION WITH PDZD11. RX PubMed=12763866; DOI=10.1111/j.1749-6632.2003.tb07230.x; RA Goellner G.M., DeMarco S.J., Strehler E.E.; RT "Characterization of PISP, a novel single-PDZ protein that binds to all RT plasma membrane Ca2+-ATPase b-splice variants."; RL Ann. N. Y. Acad. Sci. 986:461-471(2003). RN [8] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1177 (ISOFORM WA), RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1146 (ISOFORM XA), RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1163 (ISOFORM YA), RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1132 (ISOFORM ZA), AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=18669648; DOI=10.1073/pnas.0805139105; RA Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., RA Elledge S.J., Gygi S.P.; RT "A quantitative atlas of mitotic phosphorylation."; RL Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). RN [9] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1211, PHOSPHORYLATION [LARGE RP SCALE ANALYSIS] AT SER-1165 (ISOFORM WA), PHOSPHORYLATION [LARGE SCALE RP ANALYSIS] AT SER-1134 (ISOFORM XA), PHOSPHORYLATION [LARGE SCALE ANALYSIS] RP AT SER-1151 (ISOFORM YA), PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT RP SER-1120 (ISOFORM ZA), AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE RP ANALYSIS]. RC TISSUE=Liver; RX PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014; RA Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L., RA Ye M., Zou H.; RT "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver RT phosphoproteome."; RL J. Proteomics 96:253-262(2014). CC -!- FUNCTION: This magnesium-dependent enzyme catalyzes the hydrolysis of CC ATP coupled with the transport of calcium out of the cell. CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + Ca(2+)(in) + H2O = ADP + Ca(2+)(out) + H(+) + phosphate; CC Xref=Rhea:RHEA:18105, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:29108, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, CC ChEBI:CHEBI:456216; EC=7.2.2.10; CC -!- SUBUNIT: Interacts with PDZD11. {ECO:0000269|PubMed:12763866}. CC -!- INTERACTION: CC Q01814; P01258: CALCA; NbExp=2; IntAct=EBI-1174243, EBI-1018474; CC Q01814; Q14160: SCRIB; NbExp=2; IntAct=EBI-1174243, EBI-357345; CC Q01814-1; Q63622: Dlg2; Xeno; NbExp=2; IntAct=EBI-1174262, EBI-396947; CC Q01814-1; Q8SQG9: SLC9A3R2; Xeno; NbExp=3; IntAct=EBI-1174262, EBI-1174758; CC -!- SUBCELLULAR LOCATION: Cell junction, synapse CC {ECO:0000250|UniProtKB:Q9R0K7}. Cell membrane {ECO:0000255}; Multi-pass CC membrane protein {ECO:0000255}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=8; CC Comment=There is a combination of two alternative spliced domains at CC N-terminal site A (Z, X, Y and W) and at C-terminal site C (A and B). CC So far the splice sites have only been studied independently. CC Experimental confirmation may be lacking for some isoforms.; CC Name=WB; Synonyms=AIIICI; CC IsoId=Q01814-1; Sequence=Displayed; CC Name=WA; Synonyms=AIIICII; CC IsoId=Q01814-2; Sequence=VSP_000386; CC Name=YA; Synonyms=AIICII; CC IsoId=Q01814-3; Sequence=VSP_000385, VSP_000386; CC Name=ZA; Synonyms=AICII; CC IsoId=Q01814-4; Sequence=VSP_000384, VSP_000386; CC Name=YB; Synonyms=AIICI; CC IsoId=Q01814-5; Sequence=VSP_000385; CC Name=ZB; Synonyms=AICI; CC IsoId=Q01814-6; Sequence=VSP_000384; CC Name=XA; CC IsoId=Q01814-7; Sequence=VSP_040837, VSP_000386; CC Name=XB; CC IsoId=Q01814-8; Sequence=VSP_040837; CC -!- TISSUE SPECIFICITY: Mainly expressed in brain cortex. Found in low CC levels in skeletal muscle, heart muscle, stomach, liver, kidney and CC lung. Isoforms containing segment B are found in brain cortex and at CC low levels in other tissues. Isoforms containing segments X and W are CC found at low levels in all tissues. Isoforms containing segment A and CC segment Z are found at low levels in skeletal muscle and heart muscle. CC -!- SIMILARITY: Belongs to the cation transport ATPase (P-type) (TC 3.A.3) CC family. Type IIB subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M97260; AAA36456.1; -; mRNA. DR EMBL; L20977; AAA50877.1; -; mRNA. DR EMBL; L00620; AAA51893.1; -; mRNA. DR EMBL; X63575; CAA45131.1; -; mRNA. DR EMBL; AC018839; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC090841; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; U15688; AAA60985.1; -; mRNA. DR CCDS; CCDS2601.1; -. [Q01814-6] DR CCDS; CCDS33701.1; -. [Q01814-1] DR CCDS; CCDS82733.1; -. [Q01814-4] DR PIR; S22393; S22393. DR RefSeq; NP_001001331.1; NM_001001331.2. [Q01814-1] DR RefSeq; NP_001317540.1; NM_001330611.1. [Q01814-4] DR RefSeq; XP_005265236.1; XM_005265179.4. [Q01814-1] DR RefSeq; XP_006713238.1; XM_006713175.3. [Q01814-1] DR RefSeq; XP_011532054.1; XM_011533752.2. [Q01814-1] DR RefSeq; XP_016861970.1; XM_017006481.1. [Q01814-1] DR RefSeq; XP_016861971.1; XM_017006482.1. [Q01814-1] DR RefSeq; XP_016861972.1; XM_017006483.1. [Q01814-8] DR RefSeq; XP_016861973.1; XM_017006484.1. [Q01814-8] DR RefSeq; XP_016861975.1; XM_017006486.1. [Q01814-2] DR RefSeq; XP_016861978.1; XM_017006489.1. [Q01814-7] DR BioGRID; 106981; 143. DR ELM; Q01814; -. DR IntAct; Q01814; 111. DR MINT; Q01814; -. DR STRING; 9606.ENSP00000353414; -. DR TCDB; 3.A.3.2.40; the p-type atpase (p-atpase) superfamily. DR iPTMnet; Q01814; -. DR PhosphoSitePlus; Q01814; -. DR SwissPalm; Q01814; -. DR BioMuta; ATP2B2; -. DR DMDM; 14286115; -. DR jPOST; Q01814; -. DR MassIVE; Q01814; -. DR MaxQB; Q01814; -. DR PaxDb; Q01814; -. DR PeptideAtlas; Q01814; -. DR PRIDE; Q01814; -. DR ProteomicsDB; 57993; -. [Q01814-1] DR ProteomicsDB; 57994; -. [Q01814-2] DR ProteomicsDB; 57995; -. [Q01814-3] DR ProteomicsDB; 57996; -. [Q01814-4] DR ProteomicsDB; 57997; -. [Q01814-5] DR ProteomicsDB; 57998; -. [Q01814-6] DR ProteomicsDB; 57999; -. [Q01814-7] DR ProteomicsDB; 58000; -. [Q01814-8] DR Antibodypedia; 26012; 120 antibodies. DR Ensembl; ENST00000360273; ENSP00000353414; ENSG00000157087. [Q01814-1] DR Ensembl; ENST00000397077; ENSP00000380267; ENSG00000157087. [Q01814-6] DR Ensembl; ENST00000452124; ENSP00000414854; ENSG00000157087. [Q01814-8] DR Ensembl; ENST00000460129; ENSP00000424494; ENSG00000157087. [Q01814-4] DR Ensembl; ENST00000643662; ENSP00000495924; ENSG00000157087. [Q01814-7] DR Ensembl; ENST00000644807; ENSP00000495228; ENSG00000157087. [Q01814-4] DR Ensembl; ENST00000645850; ENSP00000494716; ENSG00000157087. [Q01814-1] DR Ensembl; ENST00000646379; ENSP00000494381; ENSG00000157087. [Q01814-6] DR GeneID; 491; -. DR KEGG; hsa:491; -. DR UCSC; uc003bvt.3; human. [Q01814-1] DR CTD; 491; -. DR DisGeNET; 491; -. DR EuPathDB; HostDB:ENSG00000157087.16; -. DR GeneCards; ATP2B2; -. DR HGNC; HGNC:815; ATP2B2. DR HPA; ENSG00000157087; Group enriched (brain, liver, salivary gland, skeletal muscle). DR MalaCards; ATP2B2; -. DR MIM; 108733; gene. DR neXtProt; NX_Q01814; -. DR OpenTargets; ENSG00000157087; -. DR Orphanet; 90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB. DR PharmGKB; PA25108; -. DR eggNOG; KOG0204; Eukaryota. DR GeneTree; ENSGT00940000161461; -. DR HOGENOM; CLU_002360_9_0_1; -. DR InParanoid; Q01814; -. DR KO; K05850; -. DR OMA; NCIMVGG; -. DR OrthoDB; 115892at2759; -. DR PhylomeDB; Q01814; -. DR TreeFam; TF300330; -. DR BRENDA; 3.6.3.8; 2681. DR PathwayCommons; Q01814; -. DR Reactome; R-HSA-418359; Reduction of cytosolic Ca++ levels. DR Reactome; R-HSA-5578775; Ion homeostasis. DR Reactome; R-HSA-936837; Ion transport by P-type ATPases. DR BioGRID-ORCS; 491; 1 hit in 866 CRISPR screens. DR ChiTaRS; ATP2B2; human. DR GeneWiki; ATP2B2; -. DR GenomeRNAi; 491; -. DR Pharos; Q01814; Tbio. DR PRO; PR:Q01814; -. DR Proteomes; UP000005640; Chromosome 3. DR RNAct; Q01814; protein. DR Bgee; ENSG00000157087; Expressed in frontal cortex and 160 other tissues. DR ExpressionAtlas; Q01814; baseline and differential. DR Genevisible; Q01814; HS. DR GO; GO:0005737; C:cytoplasm; IDA:UniProtKB. DR GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB. DR GO; GO:0098982; C:GABA-ergic synapse; IMP:SynGO. DR GO; GO:0098978; C:glutamatergic synapse; IMP:SynGO. DR GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW. DR GO; GO:0043231; C:intracellular membrane-bounded organelle; IBA:GO_Central. DR GO; GO:0005886; C:plasma membrane; IDA:UniProtKB. DR GO; GO:0098839; C:postsynaptic density membrane; IBA:GO_Central. DR GO; GO:0098793; C:presynapse; IEA:GOC. DR GO; GO:0005524; F:ATP binding; IDA:UniProtKB. DR GO; GO:0019829; F:ATPase-coupled cation transmembrane transporter activity; IBA:GO_Central. DR GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB. DR GO; GO:0005388; F:calcium transmembrane transporter activity, phosphorylative mechanism; IDA:UniProtKB. DR GO; GO:1905056; F:calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration; IMP:SynGO. DR GO; GO:0005516; F:calmodulin binding; IDA:UniProtKB. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0030165; F:PDZ domain binding; IDA:UniProtKB. DR GO; GO:0008022; F:protein C-terminus binding; IPI:UniProtKB. DR GO; GO:0006816; P:calcium ion transport; IMP:DFLAT. DR GO; GO:0006874; P:cellular calcium ion homeostasis; IBA:GO_Central. DR GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome. DR GO; GO:0030182; P:neuron differentiation; IDA:UniProtKB. DR GO; GO:1903779; P:regulation of cardiac conduction; TAS:Reactome. DR GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; IMP:DFLAT. DR GO; GO:0007605; P:sensory perception of sound; IMP:UniProtKB. DR Gene3D; 3.40.1110.10; -; 1. DR Gene3D; 3.40.50.1000; -; 1. DR InterPro; IPR030322; ATP2B2. DR InterPro; IPR022141; ATP_Ca_trans_C. DR InterPro; IPR006068; ATPase_P-typ_cation-transptr_C. DR InterPro; IPR004014; ATPase_P-typ_cation-transptr_N. DR InterPro; IPR023299; ATPase_P-typ_cyto_dom_N. DR InterPro; IPR018303; ATPase_P-typ_P_site. DR InterPro; IPR023298; ATPase_P-typ_TM_dom_sf. DR InterPro; IPR008250; ATPase_P-typ_transduc_dom_A_sf. DR InterPro; IPR036412; HAD-like_sf. DR InterPro; IPR023214; HAD_sf. DR InterPro; IPR006408; P-type_ATPase_IIB. DR InterPro; IPR001757; P_typ_ATPase. DR PANTHER; PTHR24093:SF377; PTHR24093:SF377; 1. DR Pfam; PF12424; ATP_Ca_trans_C; 1. DR Pfam; PF00689; Cation_ATPase_C; 1. DR Pfam; PF00690; Cation_ATPase_N; 1. DR SMART; SM00831; Cation_ATPase_N; 1. DR SUPFAM; SSF56784; SSF56784; 1. DR SUPFAM; SSF81653; SSF81653; 1. DR SUPFAM; SSF81660; SSF81660; 1. DR SUPFAM; SSF81665; SSF81665; 1. DR TIGRFAMs; TIGR01517; ATPase-IIB_Ca; 1. DR TIGRFAMs; TIGR01494; ATPase_P-type; 3. DR PROSITE; PS00154; ATPASE_E1_E2; 1. PE 1: Evidence at protein level; KW Alternative splicing; ATP-binding; Calcium; Calcium transport; KW Calmodulin-binding; Cell junction; Cell membrane; Ion transport; Magnesium; KW Membrane; Metal-binding; Nucleotide-binding; Phosphoprotein; KW Reference proteome; Synapse; Translocase; Transmembrane; KW Transmembrane helix; Transport. FT CHAIN 1..1243 FT /note="Plasma membrane calcium-transporting ATPase 2" FT /id="PRO_0000046214" FT TOPO_DOM 1..94 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 95..115 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 116..152 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 153..173 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 174..390 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 391..410 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 411..443 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 444..461 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 462..875 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 876..895 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 896..905 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 906..926 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 927..946 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 947..969 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 970..987 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 988..1009 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 1010..1028 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 1029..1050 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 1051..1060 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 1061..1082 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 1083..1243 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT REGION 1123..1140 FT /note="Calmodulin-binding subdomain A" FT /evidence="ECO:0000250" FT REGION 1141..1150 FT /note="Calmodulin-binding subdomain B" FT /evidence="ECO:0000250" FT COMPBIAS 294..297 FT /note="Poly-Glu" FT ACT_SITE 499 FT /note="4-aspartylphosphate intermediate" FT METAL 820 FT /note="Magnesium" FT /evidence="ECO:0000250" FT METAL 824 FT /note="Magnesium" FT /evidence="ECO:0000250" FT MOD_RES 18 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9R0K7" FT MOD_RES 1139 FT /note="Phosphothreonine; by PKC" FT /evidence="ECO:0000250|UniProtKB:P20020" FT MOD_RES 1178 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9R0K7" FT MOD_RES 1188 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q9R0K7" FT MOD_RES 1201 FT /note="Phosphoserine; by PKA" FT /evidence="ECO:0000250|UniProtKB:Q9R0K7" FT MOD_RES 1211 FT /note="Phosphoserine" FT /evidence="ECO:0000244|PubMed:24275569" FT VAR_SEQ 303..347 FT /note="Missing (in isoform ZA and isoform ZB)" FT /evidence="ECO:0000303|PubMed:1427863, FT ECO:0000303|PubMed:8428366" FT /id="VSP_000384" FT VAR_SEQ 304..334 FT /note="Missing (in isoform XA and isoform XB)" FT /evidence="ECO:0000305" FT /id="VSP_040837" FT VAR_SEQ 334..347 FT /note="Missing (in isoform YA and isoform YB)" FT /evidence="ECO:0000305" FT /id="VSP_000385" FT VAR_SEQ 1141..1243 FT /note="IRVVKAFRSSLYEGLEKPESRTSIHNFMAHPEFRIEDSQPHIPLIDDTDLEE FT DAALKQNSSPPSSLNKNNSAIDSGINLTTDTSKSATSSSPGSPIHSLETSL -> IEVV FT NTFKSGASFQGALRRQSSVTSQSQDVANLSSPSRVSLSNALSSPTSLPPAAAGQG (in FT isoform WA, isoform XA, isoform YA and isoform ZA)" FT /evidence="ECO:0000305" FT /id="VSP_000386" FT CONFLICT 92..94 FT /note="PKT -> AKP (in Ref. 1; AAA36456)" FT /evidence="ECO:0000305" FT CONFLICT 126 FT /note="P -> R (in Ref. 2; AAA50877/AAA51893)" FT /evidence="ECO:0000305" FT CONFLICT 517 FT /note="G -> D (in Ref. 2; AAA50877/AAA51893)" FT /evidence="ECO:0000305" FT CONFLICT 667..668 FT /note="DG -> EW (in Ref. 1; AAA36456)" FT /evidence="ECO:0000305" FT CONFLICT 1212 FT /note="A -> S (in Ref. 1; AAA36456)" FT /evidence="ECO:0000305" FT MOD_RES Q01814-2:1165 FT /note="Phosphoserine" FT /evidence="ECO:0000244|PubMed:24275569" FT MOD_RES Q01814-2:1177 FT /note="Phosphoserine" FT /evidence="ECO:0000244|PubMed:18669648" FT MOD_RES Q01814-3:1151 FT /note="Phosphoserine" FT /evidence="ECO:0000244|PubMed:24275569" FT MOD_RES Q01814-3:1163 FT /note="Phosphoserine" FT /evidence="ECO:0000244|PubMed:18669648" FT MOD_RES Q01814-4:1120 FT /note="Phosphoserine" FT /evidence="ECO:0000244|PubMed:24275569" FT MOD_RES Q01814-4:1132 FT /note="Phosphoserine" FT /evidence="ECO:0000244|PubMed:18669648" FT MOD_RES Q01814-7:1134 FT /note="Phosphoserine" FT /evidence="ECO:0000244|PubMed:24275569" FT MOD_RES Q01814-7:1146 FT /note="Phosphoserine" FT /evidence="ECO:0000244|PubMed:18669648" SQ SEQUENCE 1243 AA; 136876 MW; 7F10221B7B9AC3A2 CRC64; MGDMTNSDFY SKNQRNESSH GGEFGCTMEE LRSLMELRGT EAVVKIKETY GDTEAICRRL KTSPVEGLPG TAPDLEKRKQ IFGQNFIPPK KPKTFLQLVW EALQDVTLII LEIAAIISLG LSFYHPPGEG NEGCATAQGG AEDEGEAEAG WIEGAAILLS VICVVLVTAF NDWSKEKQFR GLQSRIEQEQ KFTVVRAGQV VQIPVAEIVV GDIAQVKYGD LLPADGLFIQ GNDLKIDESS LTGESDQVRK SVDKDPMLLS GTHVMEGSGR MLVTAVGVNS QTGIIFTLLG AGGEEEEKKD KKGVKKGDGL QLPAADGAAA SNAADSANAS LVNGKMQDGN VDASQSKAKQ QDGAAAMEMQ PLKSAEGGDA DDRKKASMHK KEKSVLQGKL TKLAVQIGKA GLVMSAITVI ILVLYFTVDT FVVNKKPWLP ECTPVYVQYF VKFFIIGVTV LVVAVPEGLP LAVTISLAYS VKKMMKDNNL VRHLDACETM GNATAICSDK TGTLTTNRMT VVQAYVGDVH YKEIPDPSSI NTKTMELLIN AIAINSAYTT KILPPEKEGA LPRQVGNKTE CGLLGFVLDL KQDYEPVRSQ MPEEKLYKVY TFNSVRKSMS TVIKLPDESF RMYSKGASEI VLKKCCKILN GAGEPRVFRP RDRDEMVKKV IEPMACDGLR TICVAYRDFP SSPEPDWDNE NDILNELTCI CVVGIEDPVR PEVPEAIRKC QRAGITVRMV TGDNINTARA IAIKCGIIHP GEDFLCLEGK EFNRRIRNEK GEIEQERIDK IWPKLRVLAR SSPTDKHTLV KGIIDSTHTE QRQVVAVTGD GTNDGPALKK ADVGFAMGIA GTDVAKEASD IILTDDNFSS IVKAVMWGRN VYDSISKFLQ FQLTVNVVAV IVAFTGACIT QDSPLKAVQM LWVNLIMDTF ASLALATEPP TETLLLRKPY GRNKPLISRT MMKNILGHAV YQLALIFTLL FVGEKMFQID SGRNAPLHSP PSEHYTIIFN TFVMMQLFNE INARKIHGER NVFDGIFRNP IFCTIVLGTF AIQIVIVQFG GKPFSCSPLQ LDQWMWCIFI GLGELVWGQV IATIPTSRLK FLKEAGRLTQ KEEIPEEELN EDVEEIDHAE RELRRGQILW FRGLNRIQTQ IRVVKAFRSS LYEGLEKPES RTSIHNFMAH PEFRIEDSQP HIPLIDDTDL EEDAALKQNS SPPSSLNKNN SAIDSGINLT TDTSKSATSS SPGSPIHSLE TSL //